Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/INO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Inovio Pharmaceuticals Inc (INO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

INO trades at $1.42, down 0.7% on the day, with a bullish technical signal from moving averages. The company shows consistent earnings beats but faces significant financial challenges with a net income margin of -130,000% and negative cash flow from operations. Recent developments include FDA review progress for INO-3107 with a PDUFA date of October 30, 2026, and a recent $20 million public offering to fund operations.
The investment case hinges on regulatory approval catalysts, with analysts maintaining a $3.50 price target (147% upside). However, substantial financial losses, negative profitability metrics, and reliance on financing create high risk. Success depends entirely on clinical and regulatory milestones outweighing persistent cash burn.
Read full analysis

Key Stats

  • Market Cap
    $137.00M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $2.65
  • 52W Low
    $0.66
  • Typical Hold Time
    -
  • Enterprise Value
    $108.33M
  • Div Yield
    -
  • Trading Activity
    -
$1.32
52W Low: $0.66
30 Jul 2026
52W High: $2.65
09 Oct 2025

Track Inovio Pharmaceuticals Inc (INO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $0.66 and a high of $2.65, highlighting its annual price range. Buy and sell Inovio Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Most Recent News

Content is generated by Aura AI

Agree Realty Director Rakolta buys 20,136 shares worth $1.5M

Agree Realty Director Rakolta has purchased 20,136 shares of the company, investing approximately $1.5 million. This insider buying could signal confidence in the company's future prospects. Investors may view this as a positive sign, potentially imp...

Market News
1 hour ago
Jake Lerch
Bullish
news icon
Agree Realty Director Rakolta buys 20,136 shares worth $1.5M

Chewy shares drop 10.8% despite in-line Q2 results and raised 2026 sales forecast.

Chewy reported Q2 results largely in line with expectations, with net sales up 7.3% to $3.33 billion and adjusted earnings matching forecasts at $0.36 per share. However, shares fell 10.8% due to concerns about slowing organic growth, cautious consum...

Company Fundamentals
2 hours ago
Andrew Wynn
Bearish
news icon
Chewy shares drop 10.8% despite in-line Q2 results and raised 2026 sales forecast.

Macy's Q1 earnings beat estimates; raises full-year sales forecast on strong brand growth

Macy's reported Q1 earnings per share of $0.40, exceeding the $0.37 estimate, with revenue of $4.87 billion beating expectations. Growth was driven by strong sales in Bloomingdale's, Bluemercury, and Macy's stores. The company raised its full-year ne...

Company Fundamentals
3 hours ago
Alex Lavoie
Bullish
news icon
Macy's Q1 earnings beat estimates; raises full-year sales forecast on strong brand growth
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $137.00M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $2.65
  • 52W Low
    $0.66
  • Typical Hold Time
    -
  • Enterprise Value
    $108.33M
  • Div Yield
    -
  • Trading Activity
    -
$1.32
52W Low: $0.66
30 Jul 2026
52W High: $2.65
09 Oct 2025

Track Inovio Pharmaceuticals Inc (INO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $0.66 and a high of $2.65, highlighting its annual price range. Buy and sell Inovio Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!